Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Axogen, Inc. (AXGN)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
08/18/2023
8-K
Quarterly results
08/07/2023
8-K
Quarterly results
Docs:
"
Axogen, Inc Reports 2023 Second Quarter Financial Results
",
"
in the Private Securities Litigation Reform Act of 1995. These
"
06/30/2023
8-K
Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
"
136166767.4 AMENDMENT NO. 1 TO THE TERM LOAN AGREEMENT THIS AMENDMENT NO. 1 TO THE TERM LOAN AGREEMENT,
"
05/09/2023
8-K
Quarterly results
Docs:
"
Axogen, Inc Reports 2023 First Quarter Financial Results
"
05/01/2023
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events Interactive Data
03/14/2023
8-K
Investor presentation
Docs:
"
Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results
"
03/13/2023
8-K
Regulation FD Disclosure Interactive Data
01/09/2023
8-K
Results of Operations and Financial Condition, Regulation FD Disclosure Interactive Data
Docs:
"
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022 ALACHUA and TAMPA, FL
",
"
in the Private Securities Litigation Reform Act of 1995. These
"
11/08/2022
8-K
Investor presentation, Quarterly results
Docs:
"
Axogen, Inc Reports 2022 Third Quarter Financial Results
",
"
in the Private Securities Litigation Reform Act of 1995. These
"
10/31/2022
8-K
Quarterly results
08/25/2022
8-K
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data
Docs:
"
First Amendment to Lease Agreement, by and between Axogen Corporation and Ja-Cole, L.P
",
"
Eighth Amendment to License and Services Agreement, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissue Services)
"
08/03/2022
8-K
Quarterly results
07/18/2022
8-K
Quarterly results
07/11/2022
8-K
Quarterly results
05/26/2022
8-K
Quarterly results
05/04/2022
8-K
Quarterly results
04/01/2022
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
"
AXOGEN, INC. PERFORMANCE-BASED RESTRICTED STOCK UNITS NOTICE UNDER THE AXOGEN, INC. AMENDED AND RESTATED 2019 LONG-TERM INCENTIVE PLAN
",
"
AXOGEN, INC. RESTRICTED STOCK UNITS NOTICE UNDER THE AXOGEN, INC. AMENDED AND RESTATED 2019 LONG-TERM INCENTIVE PLAN
",
"
AXOGEN, INC. INCENTIVE STOCK OPTION NOTICE
",
"
AXOGEN, INC. PREMIUM INCENTIVE STOCK OPTION NOTICE
"
02/22/2022
8-K
Quarterly results
01/31/2022
8-K
Entry into a Material Definitive Agreement Interactive Data
Docs:
"
DocuSign Envelope ID: 9BB348B7-E5AC-4762-8091-E9B018D62080 DocuSign Envelope ID: 9BB348B7-E5AC-4762-8091-E9B018D62080 CEO 1/27/2022 Karen Zaderej
"
01/10/2022
8-K
Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I...
Docs:
"
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2021 ALACHUA and TAMPA, FL
",
"
As of December 31, 2021
"
11/03/2021
8-K
Quarterly results
Docs:
"
Axogen, Inc. Reports 2021 Third Quarter Financial Results ALACHUA and TAMPA, FL
",
"
As of September 30, 2021
"
09/01/2021
8-K
Quarterly results
08/04/2021
8-K
Quarterly results
07/19/2021
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
"
Axogen, Inc. Appoints John H. Johnson to Board of Directors
"
07/16/2021
8-K
Quarterly results
05/17/2021
8-K
Quarterly results
05/10/2021
8-K
Quarterly results
05/05/2021
8-K
Quarterly results
02/26/2021
8-K
Quarterly results
02/22/2021
8-K
Quarterly results
02/18/2021
8-K
Quarterly results
01/14/2021
8-K
Quarterly results
01/11/2021
8-K
Quarterly results
01/06/2021
8-K
Quarterly results
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy